Panel Discussion: Evaluating Investor Interest in Next-Generation Gene Therapy Technologies

Time: 5:00 pm

Details:

• What innovation in gene therapy vector development makes for an attractive investment proposition?
• What differentiating factors and data packages are big pharma looking for to acquire or collaborate with new startups?
• Looking beyond rare disease: are investors confident that better delivery tools could enable gene therapy success in more prevalent conditions?